R3 logo

R3 Funding & Investors

R3 Vascular creates bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease. R3 Vascular's polymer and proprietary technologies are used to create scaffolds that balance strength and flexibility for the treatment of peripheral arterial disease. The magnitude BRS device is the thinnest BRS ever tested in this clinical setting, with a strut thickness of 98 microns across its entire usable range of diameters.

r3vascular.com

Total Amount Raised: $104,800,000

R3 Funding Rounds

  • Series B

    $87,000,000

    Series B Investors

    Deerfield Management
    415 Capital
  • Series A

    $17,800,000

    Series A Investors

    415 Capital
Funding info provided by Diffbot.